Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents

Pharmacology, Toxicology and Pharmaceutical Science

• Pyrimidine Derivative 100%
• Anticarcinogen 100%
• Malignant Neoplasm 66%
• Chemotherapy 33%
• Anticonvulsive Agent 33%
• Mammalian Target of Rapamycin 33%
• Cyclin Dependent Kinase 33%
• Antipyretic Agent 33%
• Antiinfective Agent 33%
• Dihydrofolate Reductase 33%
• Mitogen Activated Protein Kinase P38 33%
• Phosphotransferase 33%
• Phosphatidylinositol 3 Kinase 33%
• Protein Tyrosine Kinase 33%
• Protein Kinase 33%
• Fibroblast Growth Factor Receptor 33%
• Phosphodiesterase 33%

Keyphrases

• Selective Cancer Therapy 25%
• Pyrimidine Derivatives 25%
• Antipyretic Activity 25%
• Depressive 25%
• Extracellular Regulated Protein Kinases 25%
• BCR-ABL 25%